Skip to search formSkip to main contentSkip to account menu

U 76252

Known as: U-76,252 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cefpodoxime proxetil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae
Cefpodoxime proxetil is an oral cephalosporin antibiotic. The in vitro activities of cefpodoxime (the active metabolite of… 
1989
1989
In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis
Cefpodoxime proxetil (U-76,252; CS-807) is a new esterified oral cephem antibiotic with a broad antibacterial spectrum. Since… 
Highly Cited
1988
Highly Cited
1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)
Compound U-76,253A (R-3746), the active metabolite sodium salt of the prodrug ester U-76,252 (CS-807), was demonstrated to be… 
1988
1988
In vitro activity of U-76,252 (CS-807), a new oral cephalosporin
U-76,252 is the prodrug of U-76,253. MICs of U-76,253 were 0.015 to 0.06 microgram/ml for greater than or equal to 90% of the… 
1988
1988
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
1987
1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)